Alumis, Inc. (ALMS)
6.78
-0.04
(-0.59%)
USD |
NASDAQ |
Oct 23, 16:00
6.79
+0.01
(+0.15%)
After-Hours: 20:00
Alumis Price to Book Value : 1.927 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.927 |
| October 22, 2026 | 1.938 |
| October 21, 2026 | 1.935 |
| October 20, 2026 | 1.904 |
| October 19, 2026 | 1.802 |
| October 16, 2026 | 1.739 |
| October 15, 2026 | 1.793 |
| October 14, 2026 | 1.722 |
| October 13, 2026 | 1.864 |
| October 12, 2026 | 2.006 |
| October 09, 2026 | 2.035 |
| October 08, 2026 | 1.981 |
| October 07, 2026 | 1.924 |
| October 06, 2026 | 1.970 |
| October 05, 2026 | 1.944 |
| October 02, 2026 | 1.947 |
| October 01, 2026 | 2.049 |
| September 30, 2026 | 2.100 |
| September 29, 2026 | 2.072 |
| September 28, 2026 | 2.035 |
| September 25, 2026 | 2.018 |
| September 24, 2026 | 2.072 |
| September 23, 2026 | 2.114 |
| September 22, 2026 | 2.305 |
| September 21, 2026 | 2.245 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.208 |
| September 17, 2026 | 2.222 |
| September 16, 2026 | 2.257 |
| September 15, 2026 | 2.387 |
| September 14, 2026 | 2.620 |
| September 11, 2026 | 2.609 |
| September 10, 2026 | 2.814 |
| September 09, 2026 | 2.785 |
| September 08, 2026 | 3.007 |
| September 04, 2026 | 3.155 |
| September 03, 2026 | 3.229 |
| September 02, 2026 | 2.942 |
| September 01, 2026 | 2.691 |
| August 31, 2026 | 6.198 |
| August 28, 2026 | 6.360 |
| August 27, 2026 | 6.596 |
| August 26, 2026 | 6.713 |
| August 25, 2026 | 6.810 |
| August 24, 2026 | 6.545 |
| August 21, 2026 | 6.869 |
| August 20, 2026 | 6.497 |
| August 19, 2026 | 6.818 |
| August 18, 2026 | 7.071 |
| August 17, 2026 | 7.247 |
| August 14, 2026 | 7.193 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.789 |
| Corcept Therapeutics, Inc. | 13.13 |
| Aclaris Therapeutics, Inc. | 4.209 |
| BioAge Labs, Inc. | 0.6227 |
| ANI Pharmaceuticals, Inc. | 2.793 |
Price to Book Value Related Metrics
| PS Ratio | 105.75 |
| Price | 6.78 |
| Earnings Yield | -56.18% |
| Market Cap | 871.27M |